Is addiction's collateral damage culturally invariant?

By Humphreys Keith  

Addiction Research and Theory, Vol. 14, Iss. 6, 2006-12 ,pp. : 647-648

Informa Healthcare

Access to resources Recommend Favorite

Collateral Damage: Contribution of Peripheral Inflammation to Neurodegenerative Diseases

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 21, 2015-01 ,pp. : 2193-2210

Bentham Science Publishers

Access to resources Recommend Favorite

Collateral Damage Control in Cancer Therapy: Defining the Stem Identity in Gliomas

By  

Current Pharmaceutical Design, Vol. 17, Iss. 23, 2011-08 ,pp. : 2370-2385

Bentham Science Publishers

Access to resources Recommend Favorite

Tolerance Induction During Therapy with Long-Acting Nitrates: How Extensive is the “Collateral Damage”?

By Horowitz John  

Cardiovascular Drugs and Therapy, Vol. 18, Iss. 1, 2004-01 ,pp. : 11-12

Springer Publishing Company

Access to resources Recommend Favorite

Uterine sarcoma dissemination during myomectomy: If not “acceptable collateral damage,” is it possible to mitigate the risk?

By Judson Ian R.   Miah Aisha B.  

Cancer, Vol. 120, Iss. 20, 2014-10 ,pp. : 3100-3102

Blackwell Publishing

Access to resources Recommend Favorite